Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 28 days ago
Share
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
1401 patients around the world
Available in
Mexico, United States
Boehringer Ingelheim
1401
Patients around the world
Requirements for the patient
To 51 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Sponsor
Boehringer Ingelheim
Study type
Interventional
Requirements
To 51 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05211947
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent